Related Experiment Video

Updated: Oct 17, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

HMG-CoA reductase inhibitors (statins): a promising approach to stroke prevention

D C Hess1, A M Demchuk, L M Brass

  • 1Department of Neurology, Medical College of Georgia and Veterans Affairs Medical Center, Augusta 30904, USA. dhess@neuro.mcg.edu

Neurology
|February 26, 2000
PubMed

Insights

Statins show promise in preventing strokes, potentially through cholesterol reduction and other mechanisms. Further research is needed, especially in elderly populations.

Area of Science:

  • Cardiovascular Medicine
  • Neurology
  • Pharmacology

Background:

  • Statins are a class of drugs used to lower cholesterol.
  • Coronary artery disease (CAD) is a major risk factor for stroke.
  • Emerging evidence suggests statins may have neuroprotective effects beyond lipid lowering.

Purpose of the Study:

  • To review the evidence for statin use in stroke prevention.
  • To explore potential non-cholesterol-related mechanisms of statin action in stroke.
  • To identify gaps in current research regarding statins and stroke.

Main Methods:

  • Review of randomized controlled trials (RCTs) in middle-aged patients with CAD.
  • Analysis of preclinical studies using murine stroke models.
  • Evaluation of evidence for specific statins like pravastatin and simvastatin.

Main Results:

  • Statins reduce stroke incidence in middle-aged patients with CAD.
  • Stroke risk reduction may involve pleiotropic effects on endothelial cells, macrophages, platelets, and smooth muscle cells.
  • Statins demonstrated neuroprotective effects by reducing cerebral infarction size in a mouse model.

Conclusions:

  • Pravastatin and simvastatin are effective for stroke prevention in specific patient groups.
  • Statins offer benefits beyond lipid-lowering, suggesting pleiotropic effects.
  • Further investigation of statins in stroke populations, particularly the elderly, is warranted.

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Ischemic Stroke l: Introduction01:15

Ischemic Stroke l: Introduction

Ischemic stroke is an acute cerebrovascular condition in which blood flow to a brain region is suddenly interrupted, leading to tissue infarction. Neurons depend on continuous oxygen and glucose supply, so even brief reductions in perfusion cause energy failure, ionic imbalance, and irreversible injury. Ischemic strokes are classified into thrombotic and embolic types based on their underlying mechanisms.Thrombotic MechanismsThrombotic stroke develops when a clot forms within a cerebral artery.
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...